Researchers evaluated the safety and efficacy of tofacitinib for the treatment of patients with ankylosing spondylitis.
Study authors evaluated the prevalence of axial spondyloarthritis in patients with inflammatory bowel disease in secondary care.
Researchers assessed whether the gut microbiome in ankylosing spondylitis and inflammatory bowel disease was different, and whether it correlated with disease activity.
Researchers evaluated the effect of ixekizumab on self-reported functioning and health in patients with active nonradiographic axial spondyloarthritis.
Researchers explored the determinants of impaired spinal and hip mobility in patients with early axial spondyloarthritis.
Researchers evaluated the changes in serum levels of different regulators and markers of bone formation in patients with early axial spondyloarthritis.
Researchers evaluated the predictive value of the Ankylosing Spondylitis Work Instability Scale on work impact in axial spondyloarthritis.
Researchers evaluated the association between vitamin D deficiency and inflammatory activity in patients with spondyloarthritis.
Researchers assessed whether the reason to discontinue the first TNF inhibitor (TNFi) affected the response to the second TNFi in axial spondyloarthritis.
Researchers evaluated the role of anti-CD74 antibodies in the diagnosis of axial spondyloarthritis and their association with disease duration and activity.